Emergency Access to Insulin Act of 2023

The Emergency Access to Insulin Act of 2023 creates a federal grant program to help uninsured and underinsured individuals access insulin at no cost. It authorizes the Secretary to provide grants to states, Indian tribes, and tribal organizations to establish programs that issue insulin cards allowing eligible individuals to get insulin from participating pharmacies without cost. The program requires states/tribes to provide matching funds (1:3 federal to non-federal ratio) and limits administrative costs to 10% of grant funds. Additionally, the bill imposes a new excise tax on insulin manufacturers for price increases exceeding a certain threshold, with exemptions for price increases due to legitimate cost increases. This legislation aims to improve insulin affordability and accessibility for vulnerable populations through direct assistance and manufacturer accountability measures.